Susquehanna Fundamental Investments’s Immunome IMNM Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$552K	Buy	+26,035	New	+$557K	0.01%	543

Other funds holding IMNM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Susquehanna Fundamental Investments's IMNM Position: Q2 2026 in Review

Susquehanna Fundamental Investments opened a new position in Immunome (IMNM) in Q2 2026: 26,035 shares worth $552K. The stake represents 0.01% of the portfolio and ranks #543 among its holdings.

202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

Susquehanna Fundamental Investments held 26,035 shares of Immunome worth $552K as of Q2 2026.
Immunome was a new Susquehanna Fundamental Investments position in Q2 2026.
Immunome made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q2 2026, its #543 holding.
202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2026, filed 14 Aug 2026.